| Robyn Scatena, | |
|
30 Stevens St, Norwalk, CT 06850-3859 | |
| (203) 852-2392 | |
| (203) 852-2738 |
| Full Name | Robyn Scatena |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 18 Years |
| Location | 30 Stevens St, Norwalk, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750564993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 048635 (Connecticut) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 048635 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norwalk Hospital | Norwalk, CT | Hospital |
| Danbury Hospital | Danbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nuvance Health Medical Practice Ct Inc | 4789597691 | 648 |
News Archive
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced the launch of phase two of its direct-to-consumer advertising campaign.
Akorn, Inc., a niche specialty pharmaceutical company, today announced that it has launched Vancomycin Hydrochloride USP 125mg and 250mg capsules, the generic version of ViroPharma's Vancocin, which is indicated for the treatment of Clostridium difficile-associated diarrhea.
Analytica is a great event for us to spread the word about our products and technology and it gives us the opportunity to connect live with customers and partners from around the world.
Coherex Medical, Inc. today announced that it has closed a $16.5 million Series B Preferred Stock financing. After the close of this investment, Coherex has now raised nearly $28.0 million in equity financing from outside funding sources since inception.
› Verified 6 days ago
| Entity Name | Nuvance Health Medical Practice Ct Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407898117 PECOS PAC ID: 4789597691 Enrollment ID: O20031205000130 |
News Archive
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced the launch of phase two of its direct-to-consumer advertising campaign.
Akorn, Inc., a niche specialty pharmaceutical company, today announced that it has launched Vancomycin Hydrochloride USP 125mg and 250mg capsules, the generic version of ViroPharma's Vancocin, which is indicated for the treatment of Clostridium difficile-associated diarrhea.
Analytica is a great event for us to spread the word about our products and technology and it gives us the opportunity to connect live with customers and partners from around the world.
Coherex Medical, Inc. today announced that it has closed a $16.5 million Series B Preferred Stock financing. After the close of this investment, Coherex has now raised nearly $28.0 million in equity financing from outside funding sources since inception.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robyn Scatena, 30 Stevens St, Norwalk, CT 06850-3859 Ph: (203) 852-2392 | Robyn Scatena, 30 Stevens St, Norwalk, CT 06850-3859 Ph: (203) 852-2392 |
News Archive
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced the launch of phase two of its direct-to-consumer advertising campaign.
Akorn, Inc., a niche specialty pharmaceutical company, today announced that it has launched Vancomycin Hydrochloride USP 125mg and 250mg capsules, the generic version of ViroPharma's Vancocin, which is indicated for the treatment of Clostridium difficile-associated diarrhea.
Analytica is a great event for us to spread the word about our products and technology and it gives us the opportunity to connect live with customers and partners from around the world.
Coherex Medical, Inc. today announced that it has closed a $16.5 million Series B Preferred Stock financing. After the close of this investment, Coherex has now raised nearly $28.0 million in equity financing from outside funding sources since inception.
› Verified 6 days ago
Dr. Eve Block, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-852-2665 Fax: 203-739-8878 | |
Vittoria Gassman, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 120 Connecticut Ave, Norwalk Community Health Center, Norwalk, CT 06854 Phone: 203-899-1770 | |
Dr. Yonatan J Hillman, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 30 Stevens St Ste D, Norwalk, CT 06850 Phone: 203-852-3455 | |
Maria A Martin, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 761 Main Ave, Suite 201, Norwalk, CT 06851 Phone: 203-838-4000 Fax: 203-845-9535 | |
Xiaofei Wei, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 761 Main Ave, Suite 201, Norwalk, CT 06851 Phone: 203-838-4000 Fax: 203-845-9535 | |
Daniel Ethan Boxer, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-845-4811 Fax: 203-845-4897 | |
Dr. Caitlyn Kuwata, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 34 Maple St, Norwalk, CT 06850 Phone: 203-852-2025 |